Cancer: Drugs

(asked on 11th January 2024) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what discussions she is having with pharmaceutical organisations on releasing drugs for clinical trials for the treatment of less survivable cancers.


Answered by
Andrew Stephenson Portrait
Andrew Stephenson
Minister of State (Department of Health and Social Care)
This question was answered on 17th January 2024

In March 2021, the Government published Saving and Improving Lives: The Future of UK Clinical Research Delivery, setting out ambitions to reform clinical research delivery in the United Kingdom. This sets out how we will improve patient access to clinical trials in all areas, including cancer. This, together with the Government response to the O’Shaughnessy review backed by up to £121 million of funding, will help to drive improvements in recruitment to clinical trials and approval processes which lead to quicker study set up. Implementation of our vision for clinical trials brings together stakeholders from across the research system, including industry, and we continue to have regular engagement with industry partners through established forums.

The UK’s Cancer Mission, a key element of the Life Sciences Vision, will also bring together industry, academia, and the National Health Service to collaborate and make progress on cancer, including by driving the development and commercialisation of new cancer medicines.

Reticulating Splines